Sep 25, 2023
FSD Pharma’s Lucid-21-302 — an oral treatment candidate known as Lucid-MS, for all types of multiple sclerosis (MS) — was found safe and well tolerated across multiple doses in healthy volunteers, according to interim data from a Phase 1 clinical trial The newly...
Sep 22, 2023
Two non-pharmacological rehabilitation approaches — one using a computer program designed to improve working memory and the other involving standardized cognitive-behavioral group sessions — both improved the cognitive function of people with progressive forms of...
Sep 7, 2023
Octave Bioscience has developed a test that assesses the levels of 18 proteins in the blood and uses artificial intelligence algorithms to help predict the risk of new disease activity in multiple sclerosis (MS). The test’s validation was described in “Clinical...
Aug 25, 2023
There’s no way to go around it. This summer of 2023 has been hot, humid, and borderline unbearable! Summertime for many people means fun in the sun and outdoor activities, but for those with MS, it can be the most challenging time of the year. Many with MS...
Aug 25, 2023
Years before joining the Army crossed my mind, I was a Boy Scout. We learned all sorts of skills, earned merit badges, and, of course, spent lots of time hiking and camping. I have many fond memories of those scouting years, but one lesson I remember in particular was...
Aug 22, 2023
Healthcare professionals as well as patients should consider steps in advance By now, I’m sure you’ve seen the pictures of the wildfires that charred Maui, Hawaii. As I write this, a week after the blaze, The Associated Press reports that more than 100 people have...
